Related Experiment Video
Updated: Oct 21, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens
Dee Shortridge1, S J Ryan Arends1, Jennifer M Streit1
1JMI Laboratoriesgrid.419652.d, North Liberty, Iowa, USA.
Minocycline demonstrates high susceptibility rates against unusual Gram-negative pathogens like Burkholderia and Stenotrophomonas maltophilia. These findings support minocycline as a viable treatment option for infections caused by these bacteria.
Area of Science:
- Antimicrobial resistance
- Clinical microbiology
- Infectious diseases
Background:
- Gram-negative bacterial infections pose significant treatment challenges.
- Emerging and non-fermenting Gram-negative bacteria often exhibit resistance to common antibiotics.
- Minocycline is a tetracycline-class antibiotic with broad-spectrum activity.
Purpose of the Study:
- To evaluate the in vitro minocycline susceptibility of various Gram-negative bacterial species.
- To assess the utility of minocycline for treating infections caused by less common Gram-negative pathogens.
Main Methods:
- Analysis of 3,856 bacterial isolates collected between 2014 and 2019 as part of the SENTRY surveillance program.
- Determination of minocycline susceptibility percentages (%S) for specific species including Burkholderia, Achromobacter, Alcaligenes, Aeromonas, Chryseobacterium, and Stenotrophomonas maltophilia.
Main Results:
- High minocycline susceptibility was observed across multiple species: Achromobacter spp. (92.6%), Burkholderia cepacia complex (85.9%), Aeromonas spp. (99.2%), Chryseobacterium spp. (94.9%), Alcaligenes faecalis (88.1%), and S. maltophilia (99.5%).
- Stenotrophomonas maltophilia and Aeromonas spp. showed near-universal susceptibility to minocycline.
Conclusions:
- Minocycline exhibits favorable in vitro activity against a range of unusual Gram-negative pathogens.
- The data suggest minocycline is a potentially valuable therapeutic option for infections caused by these bacteria.
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bacterial Phylum Tenericutes
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance

